Anna V Polikarpova, Tatiana V Egorova, Evgenii A Lunev, Alexandra A Tsitrina, Svetlana G Vassilieva, Irina M Savchenko, Yuliya Y Silaeva, Alexey V Deykin, Maryana V Bardina. CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the for safety studies of RNA therapeutics.Frontiers in genome editing. 2023, 5: 1034720
Alena Shakirova, Timofey Karpov, Yaroslava Komarova, Kirill Lepik. In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization.Frontiers in genome editing. 2023, 5: 1068637
Eudald Illa-Berenguer, Peter R LaFayette, Wayne A Parrott. Editing efficiencies with Cas9 orthologs, Cas12a endonucleases, and temperature in rice.Frontiers in genome editing. 2023, 5: 1074641
Viktoria Hellekes, Denise Claus, Johanna Seiler, Felix Illner, Philipp H Schiffer, Michael Kroiher. CRISPR/Cas9 mediated gene editing in non-model nematode sp. PS1159.Frontiers in genome editing. 2023, 5: 1078359
Alexander G Allen, Cheng-Han Chung, Stephen D Worrell, Glad Nwaozo, Rebekah Madrid, Anthony R Mele, Will Dampier, Michael R Nonnemacher, Brian Wigdahl. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9.Frontiers in genome editing. 2023, 5: 1101483
Sara Fañanas-Baquero, Matías Morín, Sergio Fernández, Isabel Ojeda-Perez, Mercedes Dessy-Rodriguez, Miruna Giurgiu, Juan A Bueren, Miguel Angel Moreno-Pelayo, Jose Carlos Segovia, Oscar Quintana-Bustamante. Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides.Frontiers in genome editing. 2023, 5: 1104666
Joanna Tannous, Cole Sawyer, Md Mahmudul Hassan, Jesse L Labbe, Carrie Eckert. Establishment of a genome editing tool using CRISPR-Cas9 ribonucleoprotein complexes in the non-model plant pathogen .Frontiers in genome editing. 2023, 5: 1110279
Mara Pavel-Dinu, Simon Borna, Rosa Bacchetta. Rare immune diseases paving the road for genome editing-based precision medicine.Frontiers in genome editing. 2023, 5: 1114996
Manuel Rhiel, Kerstin Geiger, Geoffroy Andrieux, Julia Rositzka, Melanie Boerries, Toni Cathomen, Tatjana I Cornu. T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds.Frontiers in genome editing. 2023, 5: 1130736
Nikoletta Y Papaioannou, Petros Patsali, Basma Naiisseh, Panayiota L Papasavva, Lola Koniali, Ryo Kurita, Yukio Nakamura, Soteroula Christou, Maria Sitarou, Claudio Mussolino, Toni Cathomen, Marina Kleanthous, Carsten W Lederer. High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on mRNA synthesis.Frontiers in genome editing. 2023, 5: 1141618
Jonas Holst Wolff, Jacob Giehm Mikkelsen. Prime editing in hematopoietic stem cells-From to CRISPR-based treatment of blood disorders.Frontiers in genome editing. 2023, 5: 1148650
Ramya Murugesan, Karthik V Karuppusamy, Srujan Marepally, Saravanabhavan Thangavel. Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells.Frontiers in genome editing. 2023, 5: 1148693